Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · Real-Time Price · USD
52.76
+0.01 (0.02%)
At close: Apr 28, 2026, 4:00 PM EDT
52.71
-0.05 (-0.09%)
After-hours: Apr 28, 2026, 6:37 PM EDT
Soleno Therapeutics Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Soleno Therapeutics stock have an average target of 83, with a low estimate of 53 and a high estimate of 145. The average target predicts an increase of 57.32% from the current stock price of 52.76.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Soleno Therapeutics stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 5 | 5 | 1 |
| Buy | 6 | 6 | 6 | 6 | 6 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 11 | 11 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $110 → $53 | Buy → Hold | Downgrades | $110 → $53 | +0.45% | Apr 17, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $100 → $53 | Strong Buy → Hold | Downgrades | $100 → $53 | +0.45% | Apr 8, 2026 |
| TD Cowen | TD Cowen | Strong Buy → Hold Downgrades $85 → $53 | Strong Buy → Hold | Downgrades | $85 → $53 | +0.45% | Apr 7, 2026 |
| Wolfe Research | Wolfe Research | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Apr 7, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades $123 → $53 | Buy → Hold | Downgrades | $123 → $53 | +0.45% | Apr 6, 2026 |
Financial Forecast
Revenue This Year
476.88M
from 190.41M
Increased by 150.46%
Revenue Next Year
717.10M
from 476.88M
Increased by 50.37%
EPS This Year
3.97
from 0.39
Increased by 917.38%
EPS Next Year
6.69
from 3.97
Increased by 68.66%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 544.7M | 866.3M | |
| Avg | 476.9M | 717.1M | |
| Low | 425.0M | 528.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 186.1% | 81.6% | |
| Avg | 150.5% | 50.4% | |
| Low | 123.2% | 10.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 5.83 | 10.42 | |
| Avg | 3.97 | 6.69 | |
| Low | 2.64 | 3.65 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1,394.2% | 162.5% | |
| Avg | 917.4% | 68.7% | |
| Low | 575.9% | -8.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.